Malaria Treatment Market Growth Is Reshaping Competitive Advantage Across The Industry
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Malaria Treatment Market Size, Value And Growth Trends Through 2030
The malaria treatment market experienced robust expansion over recent years. From $1.61 billion in 2025, it is projected to reach $1.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.6%. The historic growth was driven by several key factors, including the high incidence of malaria across tropical areas, the extensive application of medications such as chloroquine and artemisinin, global health efforts like the WHO malaria initiatives, increased financial support for malaria-related research, and advancements in diagnostic technologies.
The malaria treatment market is anticipated to experience substantial growth in the coming years, projected to reach $2.18 billion by 2030 at a compound annual growth rate (CAGR) of 6.5%. This expansion during the forecast period is driven by factors such as the development of novel antimalarial vaccines, an increase in drug-resistant malaria strains, the adoption of digital health monitoring systems, the enhancement of healthcare infrastructure in Africa and Asia, and the growth of public-private partnerships dedicated to malaria eradication. Key trends shaping the forecast period include the rapid adoption of diagnostic technologies, the expansion of the antimalarial drug pipeline, the advancement of vaccine development programs, heightened awareness and preventive efforts, and the integration of telemedicine into malaria management practices.
Download A Free Sample Report For Comprehensive Market Insights:
Malaria Treatment Market Opportunity Drivers: What Is Creating New Revenue Potential?
The growing prevalence of malaria is anticipated to drive expansion in the malaria treatment sector moving forward. Malaria is a potentially fatal mosquito-borne illness stemming from the Plasmodium parasite, marked by recurrent fevers and flu-like symptoms. This trend has emerged due to factors such as poverty, poor access to healthcare, climate shifts, insufficient malaria prevention initiatives, and drug resistance. Malaria treatment plays a key role in managing and curing infections caused by the Plasmodium parasite. For example, in December 2024, the UK Health Security Agency—a UK-based government body—reported that imported malaria cases in the United Kingdom totaled 2,106 in 2023, a 26% increase from 2022, with England seeing 1,977 cases and the rest spread across Scotland, Wales, and Northern Ireland. Consequently, the high rate of malaria is fueling growth in the malaria treatment market.
An escalation in healthcare spending is expected to drive forward the malaria treatment market in the coming period. Healthcare spending represents the total financial resources dedicated to the health sector within a given region, country, or organization. Investment in healthcare for malaria treatment is vital for effectively controlling and halting disease spread, while also guaranteeing access to timely diagnosis, antimalarial drugs, and preventive steps. As an illustration, in April 2025, the Office for National Statistics (ONS)—an independent UK-based producer of official data—indicated that total healthcare expenditure grew 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, with healthcare’s share of GDP remaining stable at 11.1% in 2024. Thus, rising healthcare spending is propelling the malaria treatment market’s growth.
Malaria Treatment Market Segments: Where Are The Largest Growth Opportunities?
The malaria treatment market covered in this report is segmented –
1) By Treatment: Prescription Medications, Vaccines, Diagnostic Tests, Other Treatments
2) By Route Of Administration: Oral, Parenteral, Intravenous
3) By Distribution Channel: Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users
Subsegments:
1) By Prescription Medications: Antimalarial Drugs, Prophylactic Medications
2) By Vaccines: RTS,S Or AS01, Other Experimental Vaccines
3) By Diagnostic Tests: Rapid Diagnostic Tests, Microscopy-Based Tests, Polymerase Chain Reaction (PCR) Tests
4) By Other Treatments: Supportive Care, Herbal Remedies, Vector Control Measures
Malaria Treatment Market Innovation Trends Driving Future Development
Leading players within the malaria treatment sector are concentrating on initiating vaccine distribution programs to bolster prevention initiatives and lessen the worldwide impact of malaria. Such a distribution effort—referred to as a vaccine rollout—involves the systematic dissemination and administration of vaccines to a population, often conducted on a broad scale. As an example, in July 2024, Gavi, a vaccine alliance headquartered in Sweden, started the rollout of the R21 malaria vaccine. This vaccine is anticipated to substantially lower the number of malaria infections in children under five years old. The introduction of the R21 malaria vaccine marks a notable achievement in public health endeavors to fight malaria among children, with aspirations that it will result in a considerable decrease in both the disease burden and mortality rates linked to this preventable illness.
Malaria Treatment Market Major Participants And Competitive Dynamics
Major companies operating in the malaria treatment market are Pfizer Inc., Merck & Co., Johnson & Johnson, Roche Holding AG, Bayer AG, Novartis AG, Sanofi SA, AstraZeneca Plc, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Serum Institute of India, Cipla Ltd., Amneal Pharmaceuticals LLC, Lupin Ltd., Zydus Lifesciences Limited, Ipca Laboratories Ltd., Chongqing Holley Pharmaceutical Co. Ltd., Strides Pharma Science Limited, AdvaCare Pharma USA LLC, Actiza Pharmaceutical Private Limited
Access The Complete Malaria Treatment Market Report:
Malaria Treatment Market Regional Analysis And Leading Geography
Middle East and Africa was the largest region in the malaria treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the malaria treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
